A Phase 2b, Open-label, Single Dose Study to Evaluated the Safety and Efficacy of RT234 on Exercise Parameters Assessed by Cardiopulmonary Exercise Testing (CPET) in Subjects With Pulmonary Arterial Hypertension (PAH)

14087RT234-PAH-CL202Open (affiliates only)A Phase 2b, Open-label, Single Dose Study to Evaluated the Safety and Efficacy of RT234 on Exercise Parameters Assessed by Cardiopulmonary Exercise Testing (CPET) in Subjects With Pulmonary Arterial Hypertension (PAH)NCT04266197IndustrialAdultTreatmentIIOtherKrishnan, MrinaliniMedstar Washington Hospital Center : Megan FullerMCRN - Heart Failure13465Megan FullerMegan Fullermegan.a.fuller@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>